This legislation, known as the "Expanding Support for Living Donors Act of 2026," aims to enhance the Living Organ Donation Reimbursement Program by amending the Public Health Service Act. Its primary goal is to alleviate financial barriers for individuals who choose to donate organs, thereby encouraging more life-saving donations. A key provision expands eligibility for reimbursement, stipulating that grant recipients cannot limit eligibility based on income if a donor's household income is at or below 700 percent of the poverty line . The bill also sets a new reimbursement structure, establishing a maximum permissible amount of $10,000 for fiscal year 2027 , which will be adjusted annually based on the Consumer Price Index. The Secretary of Health and Human Services retains the authority to lower this maximum amount if a grant recipient has insufficient funds, provided Congress receives prior notification. Furthermore, the bill updates the program's funding authorization, allowing for "such sums as may be necessary" for fiscal years 2028 through 2037. It also mandates comprehensive annual reporting, requiring the Secretary to submit and make public detailed information on the program's funding adequacy, impacts, challenges, and future needs. These reports must include data on donor demographics, types of expenses reimbursed, and estimated savings to the Medicare program. Finally, the legislation directs the Comptroller General of the United States to conduct a study within one year of enactment. This study will examine how the Medicare program could potentially cover costs currently handled by the Living Organ Donation Reimbursement Program under existing statutory authorities, including recommendations for necessary changes.